|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_on1020318848 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
180125t20142014dcu obf 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d USU
|d YDX
|d AGLDB
|d SNK
|d DKU
|d AUW
|d MHW
|d OCLCO
|d IGB
|d D6H
|d INTCL
|d BTN
|d OCLCQ
|d VTS
|d G3B
|d S8J
|d S9I
|d STF
|d M8D
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCA
|d AJS
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 911038556
|a 962010889
|a 1196947795
|
020 |
|
|
|a 9781585624546
|q (electronic bk.)
|
020 |
|
|
|a 1585624543
|q (electronic bk.)
|
020 |
|
|
|a 9781585625338
|
020 |
|
|
|a 1585625337
|
029 |
1 |
|
|a AU@
|b 000066966135
|
035 |
|
|
|a (OCoLC)1020318848
|z (OCoLC)911038556
|z (OCoLC)962010889
|z (OCoLC)1196947795
|
050 |
|
4 |
|a RC451.4.A5
|
060 |
|
4 |
|a QV 77.2
|b J17c 2014
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.78
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Jacobson, Sandra A.,
|d 1953-
|e author.
|
245 |
1 |
0 |
|a Clinical manual of geriatric psychopharmacology /
|c Sandra A. Jacobson, M.D.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a Washington, DC :
|b American Psychiatric Association,
|c [2014]
|
264 |
|
4 |
|c ©2014
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Vendor-supplied metadata.
|
505 |
0 |
|
|a Cover; Contents; 1 Principles and Practice of Geriatric Psychopharmacology; Prescribing Principles; Psychopharmacology of the Aging Patient; 2 Antipsychotics; Pharmacokinetics; Pharmacodynamics and Mechanism of Action; Drug Interactions; Clinical Use; Adverse Effects; Treatment of Selected Syndromes and Disorders; Specific Drug Summaries; 3 Antidepressants; Pharmacokinetics; Pharmacodynamics and Mechanism of Action; Drug Interactions; Efficacy; Clinical Use; Adverse Effects; System-Specific Adverse Effects; Treatment of Selected Syndromes and Disorders
|
505 |
8 |
|
|a Medical Disorders Associated With DepressionSpecific Drug Summaries; 4 Mood Stabilizers; Pharmacology; Drug Interactions; Clinical Use; Adverse Effects; System-Specific Adverse Effects; Treatment of Selected Syndromes and Disorders; Specific Drug Summaries; 5 Anxiolytic and Sedative-Hypnotic Medications; Pharmacokinetics; Pharmacodynamics and Mechanism of Action; Drug Interactions; Indications for Benzodiazepines in Elderly Patients; Efficacy of Anxiolytics and Sedative-Hypnotics; Clinical Use; Adverse Effects; Treatment of Selected Syndromes and Disorders; Specific Drug Summaries
|
505 |
8 |
|
|a 6 Treatment of Substance-Related DisordersBasic Pharmacology of Ethanol; Alcohol-Related Disorders; Nicotine-Related Disorders; Abuse and Misuse of Prescribed Drugs; Specific Drug Summaries; 7 Treatment of Movement Disorders; Diagnostic Radiopharmaceuticals; Primary Movement Disorders; Drug-Induced Syndromes; Specific Drug Summaries; 8 Medications to Treat Neurocognitive Disorders; Diagnostic Radiopharmaceuticals; Medications Used to Treat Neurocognitive Disorders; Unlabeled Treatments for Neurocognitive Disorders; Treatments Under Investigation for Neurocognitive Disorders
|
505 |
8 |
|
|a Treatment of Specific Neurocognitive DisordersTreatment of Cognitive Difficulties Related to Schizophrenia; Treatment of Selected Neurocognitive Disorder-Related Behavioral Disturbances; Specific Drug Summaries; 9 Medications to Treat Pain; Pain Classification and Basic Mechanisms of Analgesia; Pharmacokinetics and Pharmacodynamics; Drug Interactions; Clinical Use of Analgesics and Adjuvants; Acute Analgesic Overdose; Opioid Tolerance; Adverse Effects of Analgesics by Class; System-Specific Adverse Effects; Treatment of Selected Pain Syndromes Affecting Elderly Patients
|
505 |
8 |
|
|a Specific Drug SummariesReferences; Index; A; B; C; D; E; F; G; H; I; K; L; M; N; O; P; Q; R; S; T; U; V; W; X; Z
|
520 |
|
|
|a Clinical Manual of Geriatric Psychopharmacology, Second Edition, covers all newly available drugs, new safety warnings, information about adverse effects, and efficacy for expanded or more limited indications. Information is presented as concise bulleted text, and key concepts are highlighted. Consideration has been given to DSM-5® compatibility.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Geriatric psychopharmacology
|v Handbooks, manuals, etc.
|
650 |
1 |
2 |
|a Psychotropic Drugs
|x pharmacokinetics
|
650 |
1 |
2 |
|a Psychotropic Drugs
|x therapeutic use
|
650 |
2 |
2 |
|a Aged
|x psychology
|
650 |
2 |
2 |
|a Aging
|x metabolism
|
650 |
2 |
2 |
|a Mental Disorders
|x drug therapy
|
650 |
2 |
2 |
|a Psychopharmacology
|x methods
|
650 |
|
6 |
|a Psychopharmacologie gériatrique
|v Guides, manuels, etc.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Geriatric psychopharmacology
|2 fast
|
655 |
|
2 |
|a Handbook
|
655 |
|
7 |
|a handbooks.
|2 aat
|
655 |
|
7 |
|a Handbooks and manuals
|2 fast
|
655 |
|
7 |
|a Handbooks and manuals.
|2 lcgft
|
655 |
|
7 |
|a Guides et manuels.
|2 rvmgf
|
776 |
0 |
8 |
|i Print version:
|a Jacobson, Sandra A., 1953-
|t Clinical manual of geriatric psychopharmacology.
|b Second edition.
|d Washington, DC : American Psychiatric Association, [2014]
|z 9781585624546
|w (OCoLC)911038556
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1610230
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5514869
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1610230
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 13244659
|
994 |
|
|
|a 92
|b IZTAP
|